PROTAC GDI2 Degrader-1
Compound 21 (PROTAC GDI2 Degrader-1) is a potent and selective degrader of GDI2, exhibiting robust in vivo antitumor efficacy in pancreatic cancer xenograft models. This small molecule is a valuable chemical probe for investigating GDI2-dependent oncogenic pathways in vitro and in vivo within oncology and targeted protein degradation research.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog